Cytosorbents Corp (CTSO)
NASDAQ:CTSO
Holding CTSO?
Track your performance easily

Cytosorbents (CTSO) Financial Statements

463 Followers

Cytosorbents Financial Overview

Cytosorbents's market cap is currently ―. The company's EPS TTM is $-0.356; its P/E ratio is -2.08; Cytosorbents is scheduled to report earnings on March 6, 2025, and the estimated EPS forecast is $-0.06. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 9.39M$ 9.89M$ 9.79M$ 5.81M$ 7.75M
Gross Profit$ 5.28M$ 6.50M$ 6.57M$ 2.45M$ 4.55M
EBIT$ -2.33M$ -4.14M$ -6.36M$ -9.34M$ -7.35M
EBITDA$ -1.71M$ -3.70M$ -5.91M$ -8.55M$ -6.89M
Net Income Common Stockholders$ -2.33M$ -4.14M$ -6.36M$ -5.83M$ -9.19M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 5.69M$ 8.46M$ 8.61M$ 14.13M$ 8.36M
Total Assets$ 47.80M$ 53.43M$ 47.07M$ 53.26M$ 47.58M
Total Debt$ 26.81M$ 26.77M$ 17.61M$ 18.31M$ 18.04M
Net Debt$ 21.12M$ 18.31M$ 9.00M$ 4.18M$ 9.68M
Total Liabilities$ 34.80M$ 36.69M$ 28.14M$ 29.99M$ 29.06M
Stockholders Equity$ 13.00M$ 16.74M$ 18.93M$ 23.28M$ 18.51M
Cash Flow-
Free Cash Flow$ -2.61M$ -4.85M$ -4.96M$ -6.54M$ -5.46M
Operating Cash Flow$ -2.46M$ -4.79M$ -4.83M$ -6.41M$ -5.21M
Investing Cash Flow$ -298.35K$ -119.86K$ -127.02K$ -135.92K$ -257.71K
Financing Cash Flow$ -99.03K$ 9.83M$ -571.76K$ 12.21M$ 648.32K
Currency in USD

Cytosorbents Earnings and Revenue History

Cytosorbents Debt to Assets

Cytosorbents Cash Flow

Cytosorbents Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis